These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2859304)

  • 1. Rebound insomnia and elimination half-life: assessment of individual subject response.
    Bixler EO; Kales JD; Kales A; Jacoby JA; Soldatos CR
    J Clin Pharmacol; 1985 Mar; 25(2):115-24. PubMed ID: 2859304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebound insomnia: a critical review.
    Gillin JC; Spinweber CL; Johnson LC
    J Clin Psychopharmacol; 1989 Jun; 9(3):161-72. PubMed ID: 2567741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quazepam and flurazepam: long-term use and extended withdrawal.
    Kales A; Bixler EO; Soldatos CR; Vela-Bueno A; Jacoby J; Kales JD
    Clin Pharmacol Ther; 1982 Dec; 32(6):781-8. PubMed ID: 7140142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early morning insomnia with rapidly eliminated benzodiazepines.
    Kales A; Soldatos CR; Bixler EO; Kales JD
    Science; 1983 Apr; 220(4592):95-7. PubMed ID: 6131538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam.
    Kales A; Bixler EO; Vela-Bueno A; Soldatos CR; Niklaus DE; Manfredi RL
    Clin Pharmacol Ther; 1986 Oct; 40(4):378-86. PubMed ID: 3530586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep laboratory studies of hypnotic drugs: efficacy and withdrawal effects.
    Kales A; Kales JD
    J Clin Psychopharmacol; 1983 Apr; 3(2):140-50. PubMed ID: 6132933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lormetazepam and of flurazepam on sleep.
    Adam K; Oswald I
    Br J Clin Pharmacol; 1984 May; 17(5):531-8. PubMed ID: 6733001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep laboratory study of lormetazepam in older insomniacs.
    Vogel GW
    Psychopharmacology Suppl; 1984; 1():69-78. PubMed ID: 6147842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines.
    Kales A; Scharf MB; Kales JD; Soldatos CR
    JAMA; 1979 Apr; 241(16):1692-5. PubMed ID: 430730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
    Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of an every-other-night regimen in insomniac patients: subjective hypnotic effectiveness of quazepam, triazolam, and placebo.
    Scharf MB
    J Clin Psychiatry; 1993 Jan; 54(1):33-8. PubMed ID: 8428895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midazolam: dose-response studies of effectiveness and rebound insomnia.
    Kales A; Soldatos CR; Bixler EO; Goff PJ; Vela-Bueno A
    Pharmacology; 1983; 26(3):138-49. PubMed ID: 6132414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies.
    Soldatos CR; Dikeos DG; Whitehead A
    Int Clin Psychopharmacol; 1999 Sep; 14(5):287-303. PubMed ID: 10529072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the safety profiles of benzodiazepine hypnotics.
    Roth T; Roehrs TA
    J Clin Psychiatry; 1991 Sep; 52 Suppl():38-41. PubMed ID: 1680124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response studies of lormetazepam: efficacy, side effects, and rebound insomnia.
    Kales A; Bixler EO; Soldatos CR; Mitsky DJ; Kales JD
    J Clin Pharmacol; 1982; 22(11-12):520-30. PubMed ID: 6131080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative 25-night sleep laboratory study on the effects of quazepam and triazolam on chronic insomniacs.
    Mamelak M; Csima A; Price V
    J Clin Pharmacol; 1984; 24(2-3):65-75. PubMed ID: 6143767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rebound insomnia: a new clinical syndrome.
    Kales A; Scharf MB; Kales JD
    Science; 1978 Sep; 201(4360):1039-41. PubMed ID: 684426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quazepam versus triazolam in patients with sleep disorders: a double-blind study.
    Mauri MC; Gianetti S; Pugnetti L; Altamura AC
    Int J Clin Pharmacol Res; 1993; 13(3):173-7. PubMed ID: 7901174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepine hypnotics and insomnia.
    Kales A
    Hosp Pract (Off Ed); 1990 Sep; 25 Suppl 3():7-21; discussion 22-3. PubMed ID: 1976124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam.
    Greenblatt DJ; Harmatz JS; Zinny MA; Shader RI
    N Engl J Med; 1987 Sep; 317(12):722-8. PubMed ID: 3306380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.